Skip to content

Cart

Your cart is empty

The science behind the only microalgae of its kind.

Two human randomized controlled trials. Peer-reviewed mechanistic research. Third-party tested by Eurofins every lot. Single origin. Fully traceable.

Not all microalgae are equal.

Spirulina is a cyanobacterium. Chlorella is a green alga. Both have evolved entirely in aquatic environments. Klebsormidium flaccidum is something categorically different.

Classified as a Charophyte — the same evolutionary lineage that gave rise to all terrestrial plants — Klebsormidium sits at the transition point between aquatic algae and land plants. This dual heritage produces a compound profile that neither kingdom can replicate alone: the bioactive complexity of a land plant combined with the bioavailability of a microalgae.

ZL01 is the specific patented strain cultivated by Zivolife. It is the only commercially available Klebsormidium flaccidum in the world. Every lot is grown at a single dedicated facility in Ica, Peru, third-party tested by Eurofins to AOAC and USP standards for composition, heavy metals, and microbiology, and imported under an active FDA Foreign Supplier Verification Program certificate.

cGMP Certified Eurofins Tested Every Lot GRAS Certified U.S. Patent 11,806,375 B2
Klebsormidium flaccidum microscope
CompoundPer serving (3g)Per 100gFunction
Protein2g52gComplete — all 9 essential amino acids. >90% bioavailability vs ~60–70% for spirulina.
Dietary Fiber<1g14.4gSoluble and insoluble prebiotic fiber matrix. Supports microbiome and gut barrier integrity.
Beta-glucan~0.1g~3.3gImmune modulation. Significantly higher than spirulina (<1%) or chlorella.
ALA (omega-3)~0.09g3.1gAnti-inflammatory omega-3. Dominant PUFA in lipid profile.
Iron4.3mg142mg25% DV per serving. Well-characterized range documented per lot.
Vitamin K₁64mcg2,131mcg1,780% DV per 100g. Vascular elasticity and calcium handling.
Vitamin E0.9mg29mg~20× higher than chlorella. Lipid-phase antioxidant.
Vitamin A (β-carotene)95mcg3,168mcg350% DV per 100g. Antioxidant and immune modulation.
Lutein~7mg241mgRetinal protection and antioxidative function.
Zeaxanthin~2.5mg84mgPaired with lutein — retinal and antioxidative support.
Total Carotenoids~10mg~330mgHigh antioxidant payload across multiple carotenoid classes.
Polyphenols (total)~18mg603mgNrf2 pathway activation. Antioxidant and chelation support.
Chlorophyll (total)~50mg1,671mgPorphyrin chelators. Part of heavy metal binding mechanism.
Potassium44mg1,465mgElectrolyte support. 30% DV per 100g.
Calcium5mg161mgBone health support.
Pheophorbide aPresentQuantified per lotiNOS inhibitor. IC50 0.24µM. NF-κB modulation. (See Mechanistic Research below)

Source: Eurofins Scientific, USA. Third-party tested per commercial lot. AOAC/USP methods.
Ranges documented per lot — full Certificate of Analysis available on request.

Two human randomized controlled trials.

The clinical evidence base for ZL01 includes two peer-reviewed human RCTs and a 90-day subchronic toxicity study with independent safety confirmation. The following data is drawn directly from published and registered literature.

55%
Reduction in CRP & IL-6 (inflammatory markers)
60 mg/dL
Reduction in total cholesterol
n=60 · 10 wks
Double-blind, placebo-controlled RCT

A randomized, double-blind, placebo-controlled trial in 60 overweight adults over 10 weeks found significant reductions in CRP and IL-6, total cholesterol, LDL, triglycerides, and fasting glucose. HDL increased. Body weight and body fat were reduced. No adverse effects were reported at any timepoint.

Oben, J.E. et al. (2007). Lipids in Health and Disease. DOI: 10.1186/1476-511X-6-20

RCT 2
Independent registered trial
Confirmed
Lipid and CRP benefits replicated
NCT00518960
ClinicalTrials.gov registered

A second registered, placebo-controlled trial independently confirmed the lipid-lowering and anti-inflammatory outcomes of the first study. Reproducibility across independent study populations supports the validity of the cardiovascular and inflammatory claims.

Registered trial NCT00518960. ClinicalTrials.gov. Results consistent with Oben et al. (2007).

Anti-inflammatory compounds mapped by UHPLC-MS analysis.

In vitro mechanistic study · University of Mississippi · Molecules, 2020

Researchers at the National Center for Natural Products Research used ultrahigh-performance liquid chromatography-mass spectrometry to identify the specific anti-inflammatory compounds present in ZL01.

Four classes of bioactive compounds were identified as contributing to anti-inflammatory activity: hydroxylated fatty acids, chlorophyll-derived pheophorbides, carotenoids, and glycoglycerolipids.

The most potent compound identified was pheophorbide a, which inhibited inducible nitric oxide synthase (iNOS) — a primary molecular driver of the inflammatory response — at a concentration of 0.24 µM. It also demonstrated inhibition of NF-κB, a central transcription factor in inflammatory signalling.

IC50 0.24 µM
Pheophorbide a — iNOS inhibition
In vitro · LPS-induced macrophage model · University of Mississippi, 2020

Qiu, S., Khan, S.I., Wang, M. et al. (2020). Chemometrics-assisted identification of anti-inflammatory compounds from the green alga Klebsormidium flaccidum var. zivo. Molecules, 25(5), 1048. DOI: 10.3390/molecules25051048

Flask with green algae culture

Safety margin exceeds 1,000x typical human exposure.

9.7 g/kg/day
NOAEL — highest dose tested, zero adverse effects
1,000x+
Safety margin vs. typical human exposure
0
Adverse effects observed at any dose level

A 90-day subchronic oral toxicity study established a No-Observed-Adverse-Effect Level of 9.7 grams per kilogram body weight per day — the highest dose tested. No adverse effects were observed at any dose. Genotoxicity testing was negative on both Ames assay and micronucleus assay. No cyanotoxins or harmful byproducts were detected in harvested biomass.

Steffek, A.E. et al. (2018). KALGAE (Klebsormidium flaccidum var. ZIVO) dried algal biomass — 90-day dietary toxicity study and genotoxicity studies. Toxicology Reports, 5, 959-969. PMC6169147

Regulatory & certification status:

  • GRAS certified — 21 CFR §170.30(b), expert panel review
  • Non-mutagenic confirmed — Ames assay and micronucleus assay negative
  • Non-allergenic — FASTER Act compliant
  • FDA FSVP certificate — active, validated April 2024
  • cGMP certified facility — Alimenta Algae S.A.C., Ica, Peru
  • HACCP certified
  • Non-GMO · Gluten-free · Vegan · Dairy-free
  • Organic and Kosher certifications in progress

One ingredient. The research is there.

Two human RCTs. Peer-reviewed mechanistic research. 90-day safety study with zero adverse effects. Third-party tested by Eurofins every lot. Single-origin, fully traceable, cGMP certified.

Try Zivolife for 30 days

30-day money-back guarantee  ·  No commitment on subscriptions  ·  Free shipping on subscriptions

Grown at one farm. Tested every lot. Fully traceable.

ZL01 is cultivated exclusively at the Alimenta Algae S.A.C. facility in Ica, Peru — a high-altitude coastal desert environment chosen for its solar intensity, water purity, and isolation from agricultural contamination. The Ica region provides year-round cultivation conditions unavailable in most other geographies.

The facility operates under cGMP certification with HACCP protocols. Low-temperature drying preserves all bioactive compounds and phytonutrients, yielding a 24-month shelf life. No solvents, no preservatives, no co-manufactured ingredients.

Every commercial lot is third-party tested by Eurofins in the USA for full macronutrient and micronutrient composition, heavy metals including lead, mercury, and cadmium, and complete microbiological screening before product release. Full Certificate of Analysis is available for every lot.

Processing room
Single Origin · Ica, Peru cGMP Certified HACCP Certified Eurofins Tested Every Lot FDA FSVP Validated 2024 Full Lot Traceability